78238-14-9

Basic information

• Product Name: 3-HYDROXY-5-NITROBENZOIC ACID
• Synonyms: 3-HYDROXY-5-NITROBENZOIC ACID;3-Hydroxy-5-nitrobenzoic acid 97%;3-Nitro-5-hydroxybenzoic acid
• CAS NO: 78238-14-9
• Molecular Formula: C₇H₅NO₅
• Molecular Weight: 183.12
• Product Categories: Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts;Building Blocks;C6 to C8;C7;Carbonyl Compounds;Carboxylic Acids;Chemical Synthesis;Nitro Compounds;Nitrogen Compounds;Organic Building Blocks;Oxygen Compounds;Phenols
• Mol File: 78238-14-9.mol
• Article Data: 11

Chemical Properties

• Melting Point: 190-195℃
• Boiling Point: 423.5 °C at 760 mmHg
• Flash Point: 195.3 °C
• Appearance: /
• Density: 1.631 g/cm³
• Vapor Pressure: 6.27E-08mmHg at 25°C
• Refractive Index: 1.663
• Storage Temp.: Hygroscopic, -20°C Freezer, Under inert atmosphere
• Solubility: DMSO (Slightly), Methanol (Slightly)
• PKA: 3.36±0.10(Predicted)
• Stability: Hygroscopic
• CAS DataBase Reference: 3-HYDROXY-5-NITROBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-HYDROXY-5-NITROBENZOIC ACID(78238-14-9)
• EPA Substance Registry System: 3-HYDROXY-5-NITROBENZOIC ACID(78238-14-9)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 78238-14-9(Hazardous Substances Data)

Usage

General Description

3-Hydroxy-5-nitrobenzoic acid is a chemical compound with the molecular formula C7H5NO5. It is a derivative of benzoic acid and belongs to the class of nitrobenzoic acids. 3-HYDROXY-5-NITROBENZOIC ACID is a yellow crystalline powder that is sparingly soluble in water. It is primarily used as an intermediate in the synthesis of pharmaceuticals, dyes, and pigments. Additionally, 3-Hydroxy-5-nitrobenzoic acid has been investigated for its potential antimicrobial and anti-inflammatory properties, making it a subject of interest in the field of medicinal chemistry. However, it is important to handle this compound with caution as it may pose health and environmental risks.

InChI:InChI=1/C7H5NO5/c9-6-2-4(7(10)11)1-5(3-6)8(12)13/h1-3,9H,(H,10,11)

Upstream product

• 618-84-8 3-amino-5-nitro-benzoic acid 
• 78238-13-8 3-methoxy-5-nitrobenzoic acid methyl ester 
• 78238-12-7 3-methoxy-5-nitrobenzoic acid 
• 2702-58-1 methyl 3,5-dinitrobenzoate 
• 65-85-0 benzoic acid 
• 99-34-3 3,5-dinitrobenzoic acid 

Downstream Products

• 76045-71-1 3-amino-5-hydroxybenzoic acid 
• 14206-69-0 3-amino-5-hydroxybenzoic acid hydrochloride 
• 78238-12-7 3-methoxy-5-nitrobenzoic acid 
• 78238-13-8 3-methoxy-5-nitrobenzoic acid methyl ester 
• 180628-74-4 3-hydroxy-5-nitrobenzyl alcohol 
• 92054-18-7 methyl α-(tert-butoxycarbonyl)-5-amino-m-anisate 
• 92010-05-4 5-propionamido-α-carboxy-m-anisic acid 
• 92010-01-0 methyl α-(tert-butoxycarbonyl)-5-nitro-m-anisate 
• 92010-03-2 5-benzamido-α-carboxy-m-anisic acid 
• 92010-07-6 5-octanamido-α-carboxy-m-anisic acid 
• 92010-04-3 methyl α-(tert-butoxycarbonyl)-5-propionamido-m-anisate 
• 92010-09-8 5-(p-chlorobenzamido)-α-carboxy-m-anisic acid 
• 92010-13-4 5-(p-bromobenzamido)-α-carboxy-m-anisic acid 
• 92010-02-1 methyl α-(tert-butoxycarbonyl)-5-benzamido-m-anisate 

Relevant articles and documents

As neuroprotective agents of pharmaceutical compounds

The invention discloses a medicinal compound as a neuroprotective agent. The medicinal compound is a neuronal nitric oxide synthase-postsynaptic density protein 95 (nNOS-PSD95) decoupling agent. The medicinal compound is a benzene ring derivative shown in the general formula (I) or its pharmaceutically acceptable salt. The invention further discloses a preparation method of the medicinal compound and a use of the medicinal compound in prevention and treatment on neuronal damage influence-caused diseases.

Synthesis of an Advanced Fragment of (+)-Trienomycinol

The synthesis of the fully functionalized eastern fragment of trienomycins A-F, ansamycin antibiotics is described. A key step involves a peptidic coupling between a sulfonyl aniline and an enantiopure carboxylic acid obtained by a completely diastereosel

NOVEL TRICYCLIC DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

The present invention relates to a novel tricyclic derivative with efficient inhibitory activity against poly(ADP-ribose)polymerases (PARP) or pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition containing the same. The tricyclic derivative of the invention is useful for the prevention or treatment of diseases caused by excess PARP activity, especially neuropathic pain, neurodegenerative diseases, cardiovascular diseases, diabetic nephropathy, inflammatory diseases, osteoporosis, and cancer, by inhibiting the activity of poly(ADP-ribose)polymerases.